Primsol (Aytu BioScience, Inc.)


Welcome to the PulseAid listing for the Primsol drug offered from Aytu BioScience, Inc.. This Dihydrofolate Reductase Inhibitor Antibacterial [EPC],Dihydrofolate Reductase Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Aytu BioScience, Inc.
NON-PROPRIETARY NAME: trimethoprim hydrochloride
SUBSTANCE NAME: TRIMETHOPRIM HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Dihydrofolate Reductase Inhibitor Antibacterial [EPC],Dihydrofolate Reductase Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-09-15
END MARKETING DATE: 2018-01-01


Primsol HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPrimsol from Aytu BioScience, Inc.
LABELER NAME: Aytu BioScience, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/5mL)
START MARKETING DATE: 2015-09-15
END MARKETING DATE: 2018-01-01
PRODUCT ID: 69654-501_5f05abe9-a9f2-48df-8edf-9616dc14fc8a
PRODUCT NDC: 69654-501
APPLICATION NUMBER: NDA074973

Other TRIMETHOPRIM HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Allegis Holdings, LLCPrimSol
Aytu BioScience, Inc.Primsol
FSC Laboratories, IncPrimsol
Key Therapeutics, LLCTRIMPEX